Obecabtagene Autoleucel in Adults with B-Cell Acute Lymphoblastic Leukemia | NEJM
Obecabtagene autoleucel (obe-cel) is an autologous 41BB-ζ anti-CD19 chimeric antigen receptor (CAR) T-cell therapy which uses an intermediate-affinity CAR to reduce toxic effects and improve persis…